Oluwole O Olalekan

40PUBLICATIONS
166CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Dec 04, 2025
Outpatient Administration of Bispecific Antibody Therapy for Hematologic Malignancies: A Practical Guide.

Kian J Rahbari, Raul Del Toro Mijares, Kathryn Kennedy

|Oct 16, 2025
Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma.

Sattva S Neelapu, Julio C Chavez, Alison R Sehgal

|Mar 25, 2025
Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial.

Bhagirathbhai Dholaria, Shakthi T Bhaskar, Vivek G Patel

Pageof 7